Table 4.

Brain activation during drug imagery^a

Cluster	Anatomical region	Extent (voxels)	x	y	z	Peak F	Peak Z
1	Left mid frontal gyrus (BA8)	7	−24	17	64	13.44	5.45
2	Left mid frontal gyrus (BA46)	4	−33	56	19	11.24	4.98
3	Left BA6, BA44, BA45	171	−51	26	25	17.64	6.20
	Left mid frontal gyrus (BA44)	69	−39	11	34
	Left precentral gyrus (BA6)	14	−36	2	61
	Left inferior frontal gyrus (BA45)	88	−51	26	25
4	Left inferior frontal gyrus (BA45)	17	−48	44	7	14.14	5.59
5	Left supplementary motor area (BA32)	8	−6	20	46	12.07	5.16
6	Left posterior cingulum	24	−3	−34	31	15.01	5.75
7	Left inferior parietal lobe (BA40)	170	−36	−58	40	16.60	6.30
8	Left angular gyrus	19	−57	−46	28	12.81	5.32
9	Left precuneus (BA7)	19	−9	−67	43	14.99	5.75
10	Left mid temporal gyrus (BA21) posterior	28	−63	−43	−5	17.85	6.23
11	Left mid temporal gyrus (BA21) anterior	70	−60	−13	−11	14.71	5.70
12	Right mid temporal gyrus (BA21) anterior	194	51	−25	−8	26.27	7.34
13	Left/right caudate/thalamus	245	0	−10	10	16.51	6.02
	Left caudate	62	−18	5	19
	Left thalamus	64	−3	−10	10
	Right caudate	38	18	5	16
	Right thalamus	52	3	−7	7
14	Left cerebellum (crus I/II)	118	−36	−61	−32	17.85	6.23
15	Right cerebellum (crus I/II)	224	15	−79	−35	20.23	6.59
16	Left brainstem	11	−3	−28	−14	13.77	5.52
17	Right brainstem	7	15	−25	−11	12.23	5.20

^aWhole-brain analysis revealed significant activation during drug imagery (relative to baseline imagery), for at least one of the four drug-setting conditions, in the clusters listed (P_FWE < 0.05 at the voxel level). Post hoc analyses indicated significant drug × setting × time interaction in the regions in bold.